By the end of 2018, through 10 years of continuous research and development, we have successfully developed : Small molecule targeted anti-tumor products: 21 projects ,such as Gefitinib, Erlotinib, Pazopanib, Lapatinib, Afatinib, Lenvatinib,etc; Diabetes products: 16 items ,such as Sitagliptin, Linagliptin,Alogliptin, Dapagliflozin, and Canagliflozin,etc; Anti-Cardiovascular products: 7 projects ,including Apixaban, Rivaroxaban, Betrixaban, and Dofetilide;
ANQING CHICO PHARMACEUTICAL CO.,LTD.
Country: 
China (Mainland)
Business Type: Trading Company
Premiumsupplier
Ms.JIANG
Tel: +86-13057662806
2-Cyanobenzyl bromideCAS NO.: 22115-41-9
4-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidineCAS NO.: 479633-63-1
Nilotinib Hydrochloride MonohydrateCAS NO.: 923288-90-8
tert-Butyl 4-(4-iodo-1H-pyrazol-1-yl)piperidine-1-carboxylateCAS NO.: 877399-73-0
(E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazoleCAS NO.: 886230-77-9
1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl esterCAS NO.: 503614-91-3
N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamideCAS NO.: 262368-30-9
6-broMo-2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-oneCAS NO.: 1016636-76-2
(3R,4S,5R,6R)-3,4,5-tris(triMethylsilyloxy)-6-((triMethylsilyloxy)Methyl)tetrahydro-2H-pyran-2-oneCAS NO.: 32384-65-9
4-[5-(4-Pentyloxyphenyl)isoxazol-3-yl]benzoic acidCAS NO.: 179162-55-1
